Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) shares saw unusually-strong trading volume on Thursday . Approximately 6,826,500 shares changed hands during mid-day trading, an increase of 1,274% from the previous session’s volume of 496,659 shares.The stock last traded at $1.75 and had previously closed at $1.37.

Separately, ValuEngine upgraded shares of Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 11th.

TRADEMARK VIOLATION NOTICE: This piece was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.

Receive News & Stock Ratings for Ampio Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.